6-type combined immunotherapy
What is a 6-component combination immunotherapy?
While surgery, chemotherapy, and radiation therapy are widely known as the three main treatments for cancer, all of them place a significant burden on the body, and many patients are unable to continue treatment due to physical limitations.
Six-component combination immunotherapy is a type of cancer treatment called "immunotherapy," in which immune cells that attack cancer cells are extracted from the blood, artificially proliferated and activated, and then returned to the body to enhance the body's ability to fight cancer.
The functions of six types of immune cells
1. Dendritic cells
It transmits cancer information to other immune cells and issues attack commands.
2. NK cells
Attack cancer as soon as it is detected.
3. Killer T cells
Receiving instructions from dendritic cells, it attacks cancer cells.
4. NKT cells
Activates other immune cells
5. Gamma delta T cells
It attacks cancer cells that other immune cells have overlooked.
6. Helper T cells
Supports other immune cells
Because six types of immune cells work together as a team to attack cancer, a higher effectiveness can be expected.
Furthermore, the treatment is performed only through blood sampling and intravenous infusion, so hospitalization is not necessary.
Treatment effectiveness rate
The cancer progression suppression rate is 79%.
Survey period: June 2020 - July 2024
Of the 380 cancer patients who received six cycles of six-component combination immunotherapy, 79% were able to suppress the progression of their cancer.
After doctors assessed the tumor size of cancer patients who underwent a course of six treatments, the disease progression suppression rate was approximately 79% (300 out of 380 patients).
Treatment flow of 6-component combination immunotherapy
A treatment plan is created with six sessions, each occurring every three weeks, forming one course of treatment. The treatment typically takes about four months.
If you undergo any blood tests, MRI scans, CT scans, or tumor marker measurements during your treatment period, please report the results to your doctor. This information will be used to inform your treatment.
Treatable cancer types
In six-component combination immunotherapy, by providing immune cells with information (peptides) to attack cancer, it is possible to attack almost all types of cancer, with the exception of some blood cancers.
We have a proven track record of treating not only common cancers such as stomach cancer, pancreatic cancer, lung cancer, and breast cancer, but also conditions that are considered difficult to treat, such as osteosarcoma and brain tumors, as well as rare cancers such as parotid gland cancer.
Features of the 6-component combination immunotherapy
With few side effects and minimal burden
Six-component combination immunotherapy is a treatment method that utilizes immune cells already present in the patient's body. Only a small amount of blood is required, and hospitalization is not necessary. The cultured, activated, and proliferated immune cells are returned to the body via intravenous infusion. The treatment time is short, approximately 20-30 minutes, and side effects are minimal, thus reducing the burden on the patient.
Culture facility approved by the Ministry of Health, Labour and Welfare based on patented technology
The cell culture technology used in our six-component combination immunotherapy is patented in both Japan and South Korea. Furthermore, the immune cells are cultured at a Cell Processing Center (CPC) authorized by the Ministry of Health, Labour and Welfare. Cell culture is carried out under a highly rigorous safety and hygiene management system.
Treatment course of 6 types of combined immunotherapy
6-type combined immunotherapy “BASIC”
It is suitable for cancer prevention and improving immunity.
6-type combined immunotherapy “CSC”
Six-component combination immunotherapy is a treatment method that uses peptides, including WT1 peptide, to strengthen the patient's immune system and fight cancer cells.
It is effective in many cancer cases, and is particularly used for cancer prevention and preventing recurrence after surgery. However, it does not have the same effect on all cases, and the treatment method must be selected according to the patient's health condition and the type of cancer.
Click here for details
For more details, please check the official website for the 6-component combination immunotherapy.
